With next-generation sequencing and CAR-T therapy entering the market, the age of precision medicine is upon us. How will individualized treatment revolutionize healthcare as we know it? Dimensions to be addressed: - Globalizing access and affordability - Redesigning data governance - Navigating ethical complexities · Nancy Brown, Chief Executive Officer, American Heart Association, USA · Jay Flatley, Executive Chairman, Illumina, USA · Scott Gottlieb, Commissioner, United States Food & Drug Administration · Vasant Narasimhan, Global Head, Drug Development; Chief Executive Officer-designate, Novartis Pharma, Switzerland · Tan Chorh Chuan, Executive Director, Office for Healthcare Transformation, Ministry of Health of Singapore Moderated by · Linda Pizzuti Henry, Managing Director, Boston Globe, USA http://www.weforum.org/